The unaudited financial results for quarter and half year ended September 30, 2025 has been approved by Implementation and Monitoring Committee in its meeting held on December 27, 2025
Awaiting price reaction for this filing.
Dharti Proteins Limited (formerly Devika Proteins), currently under Corporate Insolvency Resolution Process (CIRP) since April 29, 2024 per NCLT Ahmedabad, disclosed its financial results through the Monitoring Committee. The company had zero revenue from operations in FY25 with only Rs. 7.20 lakhs of other income, posting a small net loss of Rs. 0.66 lakhs. For Q1 FY26 (June 30, 2025), other income was Rs. 2.29 lakhs with a loss of Rs. 4.60 lakhs, while Q2 FY26 (September 30, 2025) had only Rs. 0.20 lakhs income and a loss of Rs. 0.42 lakhs. The statutory auditor (N.S. Nanavati & Co.) issued a qualified opinion on all periods, flagging going concern issues, MSMED Act compliance gaps, doubtful loans and advances of Rs. 150.46 lakhs, and inability to verify other current assets. Net worth turned negative (-Rs. 3.75 lakhs as of June 30, 2025) and contingent liabilities of Rs. 150.82 lakhs (mostly income tax and sales tax demands) are pending. Listing fees to BSE remain unpaid.
Shareholders face severe distress signals — the company is essentially non-operational, under CIRP, and audited by a qualified opinion that questions its ability to continue as a going concern. Recovery prospects depend on the CIRP resolution plan; stock remains highly risky and illiquid. Expect continued scrutiny from exchanges and no near-term value unlocking unless a successful resolution plan is approved.